Author information:
(1)Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, 
60 Biopolis Street, Genome #02-01, Singapore 138672, Singapore.
(2)Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, 8 
College Road, Singapore 169857, Singapore.
(3)NUS Graduate School for Integrative Sciences and Engineering, National 
University of Singapore, 5 Lower Kent Ridge Road, Singapore 119074, Singapore.
(4)Cancer Science Institute of Singapore, National University of Singapore, 14 
Medical Drive, #12-01, Singapore 117599, Singapore.
(5)Department of Physiology, Yong Loo Lin School of Medicine, National 
University of Singapore, 2 Medical Drive #04-01, Singapore 117597, Singapore.
(6)Department of Human Genetics, Genome Institute of Singapore, 60 Biopolis 
Street, Genome #02-01, Singapore 138672, Singapore.
(7)Medical Research Council (MRC) Molecular Haematology Unit, Weatherall 
Institute of Molecular Medicine, Oxford University, Oxford OX3 9DS, UK.
(8)Department of Upper Gastrointestinal &Bariatric Surgery, Singapore General 
Hospital, Singapore 169608, Singapore.
(9)Division of Surgical Oncology, National Cancer Centre Singapore, 11 Hospital 
Drive, Singapore 169610, Singapore.
(10)Department of General Surgery, Singapore General Hospital, Singapore 169608, 
Singapore.
(11)Department of Medical Oncology, Yonsei University College of Medicine, Seoul 
120-752, South Korea.
(12)SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre 
Singapore, Singapore 168752, Singapore.
(13)Laboratory of Cancer Epigenome, Department of Medical Sciences, National 
Cancer Centre, 11 Hospital Drive, Singapore 169610, Singapore.
(14)School of Biological Sciences, Nanyang Technological University, Singapore 
637551, Singapore.
(15)Cellular and Molecular Research, National Cancer Centre, 11 Hospital Drive, 
Singapore 169610, Singapore.